As part of the European Union’s pharmaceutical legislation update, the European Commission has proposed making all antimicrobials, including OTC antifungals and antivirals, prescription-only.
Designed to combat anti-microbial resistance (AMR) – responsible for more than 35,000 deaths every year in the EU, according to the EC– the measures in the draft revised directive could see commonly used topical brands like Bayer’s Canesten thrush creams (fluconazole, clotrimazole) and Haleon’s Zovirax
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?